TickerFactsScreenerDevelopers

Dianthus Therapeutics, Inc. /DE/ (DNTH) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $51.40M2018: $58.34M2019: $65.07M2020: $58.15M2021: $131.65M2022: $15.37M2023: $132.32M2024: $22.79M2025: $51.09M$51.09M
2017Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$51.09M+124.1%
2024$22.79M-82.8%
2023$132.32M+761.2%
2022$15.37M-88.3%
2021$131.65M+126.4%
2020$58.15M-10.6%
2019$65.07M+11.5%
2018$58.34M+13.5%
2017$51.40M—